- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Diabetes
The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.
Study Links Type 1 Diabetes in Children to Increased Risk of ADHD
May 06, 2021
A study from APA 2021 suggests type 1 diabetes mellitus in adolescence was linked to increased probability of attention deficit hyperactivity disorder.
Impact of Obesity on Risk of Severe COVID-19 Among Patients in England
May 04, 2021
Data from more than 1500 general practices are providing a comprehensive overview of the impact of obesity on risk of severe COVID-19 outcomes in England—suggesting each BMI increase beyond 23 kg/m2 increased risk of hospital admission and death.
Dasiglucagon Demonstrates Superiority to Placebo for Severe Hypoglycemia in Phase 3 Trial
May 04, 2021
New information from a phase 3 trial used as part of the FDA approval is providing insight into the safety and efficacy of dasiglucagon for treatment of severe hypoglycemia in adult patients with type 1 diabetes.
FDA Approves Dapagliflozin for Treatment of Chronic Kidney Disease
May 01, 2021
With approval in late April, dapagliflozin becomes the first SGLT2 inhibitor to receive approval for treatment of chronic kidney disease, heart failure, and type 2 diabetes.
Hypertension, Albuminuria Present in Nearly 1-in-4 Cases of Pediatric Type 2 Diabetes
April 30, 2021
A study from McMaster University is providing updated information related to the prevalence of hypertension and albuminuria in younger patients with type 2 diabetes.
Phenotypes Associated with Severe COVID-19 Similar Among Patients with and without Diabetes
April 29, 2021
A systematic review and meta-analysis of data from nearly 2 dozen studies is providing new insight into the phenotypes of patients with diabetes associated with worse outcomes from COVID-19.
Age at Onset of Type 2 Diabetes Could Help Predict Risk of Dementia
April 28, 2021
An analysis of data from 10k patients in the UK suggests onset of type 2 diabetes at an earlier age could signal increased risk of dementia later in life.
Bariatric Surgery Lowers Mortality, Risk of Events in Patients with Diabetes and Obesity
April 26, 2021
A retrospective analysis of matched cohorts has led investigators to suggest bariatric surgery should be viewed as a first-line treatment for the management of obesity in patients with type 2 diabetes.
Endocrine Month in Review: April 2021
April 24, 2021
April's month in review features stories related to new diabetes medications, stem cells, disparities in care of women, and how exposure to endocrine-disrupting chemicals in pregnancy can impact mental health following delivery. Check back in during the last weekend of each month for the next Endocrine Month in Review.
Dapagliflozin Effective for Reducing CV Risk in Diabetes, Irrespective of Kidney Function
April 16, 2021
TIMI Group investigators found the effects of dapagliflozin on cardiovascular risk in patients with diabetes were comparable in those with markers of CKD and those without markers of CKD at baseline.